The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan
Open accessAbstract
Characteristics of 205 consecutive patients with hepatocellular carcinoma (HCC) admitted during 1990 to 1993 have been analyzed from the standpoint of hepatitis viral infection in Japan. Among 205 HCC patients, 71% of the patients showed positivity for hepatic C virus (HCV) antibody alone, 13% showed positivity both for HCV and HBV (HCV/HBV) antibody, 11% demonstrated HBsAg alone, and negativity of both HCV and HBV antibody in 4% only. Positivity to both HCV antibody and HBsAg was demonstrated in 1% only. Mean detection age of HCVAb-positive HCC as well as both HCV/HBV antibody-positive HCC was 62 ± 7 years, in contrast to 52 ± 13 years in HCC with HBsAg (P < .05). Male-to-female ratio among HCVAb-positive HCC was 3.3:1, in contrast to 5.5:1 among the HCV/HBVAb-positive HCC and 7:1 among HBsAg-positive HCC, but there was no significant difference in the gender distribution between these groups. More than 60% of HCVAb-positive HCC were classified into the stage of Child B and C, whereas 65% of HBsAg-positive HCC was at the stage of Child A. The severity of liver disease was confirmed by liver histology, indicating that more than 70% of the HCVAb-positive HCC and the HCV/HBVAb-positive HCC showed cirrhosis, in contrast to 50% among the HBsAg-positive HCC. Three-year survival rate of HCV Ab-positive HCC and HBV/HCVAb-positive HCC was 68% and 56%, respectively, in contrast to 47% in HBsAg-positive HCC. HCC was found at early stage among the patients receiving periodic medical checkups beforehand, and the prognosis of these HCC patients was significantly better than those who did not receive checkups. From these results, HCV-related HCC occupied over 80% of total HCC in Japan, which are characterized by older age and more severe cirrhosis, as compared with HBsAg-positive HCC. Prognosis of HCV Ab-positive HCC was not significantly better than HBsAg-positive HCC, but the periodical screening naturally improves prognosis because the cases are found usually much earlier (lead time bias) and mostly belong to slow progression type (length bias). (Hepatology 1995; 22:1027-1033.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi, S., Onji, M., & Ohta, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6547 · Cited by 1,089
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
Bruix, J., Calvet, X., Costa, J., Ventura, M., Bruguera, M., Castillo, R., María Barrera, J., Ercilla, G., María Sanchez-Tapias, J., Vall, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91015-5 · Cited by 734
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
van der Poel, C. L., Reesink, H. W., van Boven, J. J. P., Cuypers, H. T. M., Winkel, I., Exel-Oehlers, P. J., Schaasberg, W., Lelie, P. N., Weiner, A. J., Polito, A., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90942-i · Cited by 493
Cited by
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
Self-citationShiina, S., Teratani, T., Obi, S., Sato, S., Tateishi, R., Fujishima, T., Ishikawa, T., Koike, Y., Yoshida, H., Kawabe, T., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.009 · Cited by 877
Self-citationPercutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases
Tateishi, R., Shiina, S., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., Yoshida, H., Kawabe, T., & Omata, M. (2005) · Cancer · doi:10.1002/cncr.20892 · Cited by 778
Self-citationInfections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors
Uchino, K., Tateishi, R., Shiina, S., Kanda, M., Masuzaki, R., Kondo, Y., Goto, T., Omata, M., Yoshida, H., & Koike, K. (2011) · Cancer · doi:10.1002/cncr.25960 · Cited by 427
“HCC usually develops in a liver that already suffers from chronic disease, most notably because of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection.(3) In the past, HCC often was diagnosed only at a far advanced stage, and this was accompanied by a very poor prognosis.”
BackgroundSelf-citationGuidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
Ryder, S. D. (2003) · Gut · doi:10.1136/gut.52.suppl_3.iii1 · Cited by 422
Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations
Teratani, T., Yoshida, H., Shiina, S., Obi, S., Sato, S., Tateishi, R., Mine, N., Kondo, Y., Kawabe, T., & Omata, M. (2006) · Hepatology · doi:10.1002/hep.21164 · Cited by 331
Self-citationTanaka, Y., Hanada, K., Mizokami, M., Yeo, A. E. T., Shih, J. W.-K., Gojobori, T., & Alter, H. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242608099 · Cited by 331
Trevisani, F. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04119-3 · Cited by 313
Occult hepatitis B virus infection and its clinical implications
Hu, K. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00344.x · Cited by 280
Shiratori, Y., Shiina, S., Teratani, T., Imamura, M., Obi, S., Sato, S., Koike, Y., Yoshida, H., & Omata, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00008 · Cited by 274
Self-citationProposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
Tateishi, R., Yoshida, H., Shiina, S., Imamura, H., Hasegawa, K., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., et al. (2005) · Gut · doi:10.1136/gut.2003.035055 · Cited by 273
Self-citationCirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.019 · Cited by 266
Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma
Muto, Y., Moriwaki, H., & Saito, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401315 · Cited by 265
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
Yeh, S.-H., & Chen, P.-J. (2010) · Oncology · doi:10.1159/000315247 · Cited by 256
Impact of oestrogens on the progression of liver disease
Shimizu, I. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00811.x · Cited by 207
Metadata
- Authors
- Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Kanai, F., Okudaira, T., Teratani, T., Tohgo, G., Toda, N., Ohashi, M., Ogura, K., Niwa, Y., Kawabe, T., & Omata, M.
- Venue
- Hepatology
- Published
- 1995-10
- Volume
- 22
- Issue
- 4
- Pages
- 1027-1033
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2165298960
- Cited by
- 365
- References
- 30
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.